NCT02312700

Brief Summary

The study is aimed to verify the effect of an online interactive tool on patient empowerment. The tool is based on a validated psychological questionnaire administrated to breast cancer patients before their first encounter with physician.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
Completed

Started Jan 2015

Shorter than P25 for not_applicable breast-cancer

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 28, 2014

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 9, 2014

Completed
23 days until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

December 9, 2014

Status Verified

December 1, 2014

Enrollment Period

11 months

First QC Date

November 28, 2014

Last Update Submit

December 5, 2014

Conditions

Keywords

empowermentcommunicationshared decision making

Outcome Measures

Primary Outcomes (1)

  • Improvements in the Patient Empowerment Score

    Patient empowerment score will be measured in the experimental versus the control group by mean of patients' comprehension level relatively to the information doctors provided to them.

    Up to 30 min after the visit

Study Arms (2)

Interactive empowerment (IEm) group

EXPERIMENTAL

Intervention: Patients fill in the questionnaire online and their profile (obtained from their answers) is immediately sent to the physician

Behavioral: Interactive empowerment tool

Control

SHAM COMPARATOR

Intervention: Patients fill in the questionnaire online, but their profile (obtained from their answers) is not sent to the physician

Behavioral: Interactive empowerment tool

Interventions

ControlInteractive empowerment (IEm) group

Eligibility Criteria

Age18 Years - 74 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The patient is aged 18 to 74 years at randomisation.
  • The patient has been diagnosed as having a primary breast cancer requiring a radical surgery
  • The patient is able to understand the Informed Consent Form, and understand study procedures.
  • The patient has signed the Informed Consent Form.

You may not qualify if:

  • The patient has a recurrent breast cancer diagnosis
  • The patient has an overt psychiatric illness that would interfere with the measurement of the psychological variables included in the questionnaire
  • Inability to freely consent to take part in the study
  • Inability to understand the study materials.
  • Current participation in another clinical trial relating to the breast cancer treatment
  • Any condition that, in the researcher's opinion, compromises the subject's ability to meet protocol requirements or to complete the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Kondylakis H, Kazantzaki E, Koumakis L, Genitsaridi I, Marias K, Gorini A, Mazzocco K, Pravettoni G, Burke D, McVie G, Tsiknakis M. Development of interactive empowerment services in support of personalised medicine. Ecancermedicalscience. 2014 Feb 11;8:400. doi: 10.3332/ecancer.2014.400. eCollection 2014.

    PMID: 24567757BACKGROUND

Related Links

MeSH Terms

Conditions

Breast NeoplasmsEmpowermentCommunication

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesSocial BehaviorBehavior

Study Officials

  • Elisabetta Munzono, MD

    European Institute of Oncology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alessandra Gorini, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

November 28, 2014

First Posted

December 9, 2014

Study Start

January 1, 2015

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

December 9, 2014

Record last verified: 2014-12